ENDOCAN TUTHYREF network consensus recommendations: REFRACTORY FOLLICULAR-DERIVED THYROID CANCER
{{output}}
Radioactive-iodine-refractory differentiated thyroid cancer (RAIR DTC) represents 3-5% of follicular-derived DTCs, with approximately 200-300 new cases diagnosed annually in France. Median overall survival in the French RAIR DTC database is 9.5 years, undersco... ...
